849 related articles for article (PubMed ID: 19751916)
1. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
[TBL] [Abstract][Full Text] [Related]
2. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients.
Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
Alzheimers Dement; 2009 Sep; 5(5):369-74. PubMed ID: 19751915
[TBL] [Abstract][Full Text] [Related]
3. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
Mecocci P; Bladström A; Stender K
Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
[TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of a short form of the Severe Impairment Battery in Korean Alzheimer's disease patients.
Ahn IS; Kim JH; Saxton J; Kim DK
Int J Geriatr Psychiatry; 2007 Jul; 22(7):682-7. PubMed ID: 17160969
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Severe Impairment Battery for patients with Alzheimer's disease in Korea.
Suh GH; Kang CJ
Int J Geriatr Psychiatry; 2006 Jul; 21(7):626-32. PubMed ID: 16821258
[TBL] [Abstract][Full Text] [Related]
6. The Severe Cognitive Impairment Rating Scale--an instrument for the assessment of cognition in moderate to severe dementia patients.
Choe JY; Youn JC; Park JH; Park IS; Jeong JW; Lee WH; Lee SB; Park YS; Jhoo JH; Lee DY; Kim KW
Dement Geriatr Cogn Disord; 2008; 25(4):321-8. PubMed ID: 18319591
[TBL] [Abstract][Full Text] [Related]
7. Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.
Na HR; Lee SH; Lee JS; Doody RS; Kim SY
Dement Geriatr Cogn Disord; 2009; 27(1):69-75. PubMed ID: 19145080
[TBL] [Abstract][Full Text] [Related]
8. Functional disability in early Alzheimer's disease - a validation study of the Italian version of the disability assessment for dementia scale.
De Vreese LP; Caffarra P; Savarè R; Cerutti R; Franceschi M; Grossi E;
Dement Geriatr Cogn Disord; 2008; 25(2):186-94. PubMed ID: 18196940
[TBL] [Abstract][Full Text] [Related]
9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
11. A neuropsychological test battery for use in Alzheimer disease clinical trials.
Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
[TBL] [Abstract][Full Text] [Related]
12. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Performance Test: a new approach to functional assessment in Alzheimer's disease.
Burns T; Mortimer JA; Merchak P
J Geriatr Psychiatry Neurol; 1994; 7(1):46-54. PubMed ID: 8192830
[TBL] [Abstract][Full Text] [Related]
14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
[TBL] [Abstract][Full Text] [Related]
16. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
Harwood DG; Sultzer DL; Wheatley MV
Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
[TBL] [Abstract][Full Text] [Related]
17. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
[TBL] [Abstract][Full Text] [Related]
18. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
19. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
